Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ayahuasca in treatment-resistant depression
NCT02914769Phase 2Completed
- Sponsor
- Universidade Federal do Rio Grande do Norte
- Start
- Feb 2014
- Primary completion
- Dec 2016
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ayahuasca in treatment-resistant depression (TRD), sponsored by Universidade Federal do Rio Grande do Norte. Started Feb 2014; status: completed.
02
Drugs
ayahuasca
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT02914769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02914769.